Canada:
New Court Proceedings - December 2018
28 December 2018
Smart & Biggar
To print this article, all you need is to be registered or login on Mondaq.com.
For complete details about these proceedings,
click here.
PMNOC Proceedings
rivaroxaban (XARELTO): Bayer v Apotex
The preceding is intended as a timely update on Canadian
intellectual property and technology law. The content is
informational only and does not constitute legal or professional
advice. To obtain such advice, please communicate with our offices
directly.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from Canada
Update On Biosimilars In Canada – March 2024
Smart & Biggar
In this article, we provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, and market access) since our March 2023 update.